Modeling studies suggest that 23% to 42% of all prostate cancers in the US detected in screening examinations were overtreated.51 PSA screening has been shown to be associated with a 40% reduction in prostate cancer death,52 but PSA screening will continue to be controversial without a reduction in overtreatment. The gene discussed is KLK3; the disease is prostate cancer.